153 related articles for article (PubMed ID: 31157061)
1. Role of clinical oncology pharmacist in determination of pharmaceutical care needs in patients with colorectal cancer.
Tezcan S; İzzettin FV; Sancar M; Turhal NS; Yumuk PF
Eur J Hosp Pharm; 2018 Mar; 25(e1):e17-e20. PubMed ID: 31157061
[TBL] [Abstract][Full Text] [Related]
2. Identification of drug-related problems followed by clinical pharmacist interventions in an outpatient pharmacotherapy clinic.
Shahrami B; Sefidani Forough A; Najmeddin F; Hadidi E; Toomaj S; Javadi MR; Gholami K; Sadeghi K
J Clin Pharm Ther; 2022 Jul; 47(7):964-972. PubMed ID: 35218217
[TBL] [Abstract][Full Text] [Related]
3. Developing and piloting a cross-sectoral hospital pharmacist intervention for patients in transition between hospital and general practice.
Sørensen CA; Jeffery L; Falhof J; Harbig P; Roelsgaard K; Gram S; Olesen C
Ther Adv Drug Saf; 2023; 14():20420986231159221. PubMed ID: 36949765
[TBL] [Abstract][Full Text] [Related]
4. Identification of drug-related problems by a clinical pharmacist in addition to computerized alerts.
Zaal RJ; Jansen MM; Duisenberg-van Essenberg M; Tijssen CC; Roukema JA; van den Bemt PM
Int J Clin Pharm; 2013 Oct; 35(5):753-62. PubMed ID: 23715760
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacist assessment of drug-related problems among intensive care unit patients in a Turkish university hospital.
Albayrak A; Başgut B; Bıkmaz GA; Karahalil B
BMC Health Serv Res; 2022 Jan; 22(1):79. PubMed ID: 35033079
[TBL] [Abstract][Full Text] [Related]
6. Outcomes assessment of a pharmacist-directed seamless care program in an ambulatory oncology clinic.
Edwards SJ; Abbott R; Edwards J; LeBlanc M; Dranitsaris G; Donnan J; Laing K; Whelan MA; MacKinnon NJ
J Pharm Pract; 2014 Feb; 27(1):46-52. PubMed ID: 24065784
[TBL] [Abstract][Full Text] [Related]
7. Impacts of Pharmacists-Managed Oncology Outpatient Clinic on Resolving Drug-Related Problems in Ambulatory Neoplasm Patients: A Prospective Study in China.
Zhao X; Xu R; Wang Y; Zhu W; Hu H; Shen Z; Guo C; Zhang J
Inquiry; 2021; 58():469580211009662. PubMed ID: 33847148
[TBL] [Abstract][Full Text] [Related]
8. Significance of a clinical pharmacist-led comprehensive medication management program for hospitalized oncology patients.
Umar RM; Apikoglu-Rabus S; Yumuk PF
Int J Clin Pharm; 2020 Apr; 42(2):652-661. PubMed ID: 32078106
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a Clinical Pharmacist Intervention on Clinical and Drug-Related Problems Among Coronary Heart Disease Inpatients: A pre-experimental prospective study at a general hospital in Indonesia.
Sagita VA; Bahtiar A; Andrajati R
Sultan Qaboos Univ Med J; 2018 Feb; 18(1):e81-e87. PubMed ID: 29666686
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of pharmacists' interventions on drug-related problems and drug costs in patients with cancer pain.
Zhang P; Lv D; Zhao J; Sun S; Li L; Liao Y
Int J Clin Pharm; 2021 Oct; 43(5):1274-1282. PubMed ID: 33625653
[TBL] [Abstract][Full Text] [Related]
11. A pilot study to assess the pharmacy impact of implementing a chemotherapy-induced nausea or vomiting collaborative disease therapy management in the outpatient oncology clinics.
Jackson K; Letton C; Maldonado A; Bodiford A; Sion A; Hartwell R; Graham A; Bondarenka C; Uber L
J Oncol Pharm Pract; 2019 Jun; 25(4):847-854. PubMed ID: 29587608
[TBL] [Abstract][Full Text] [Related]
12. Impact of Clinical Pharmacist-led Interventions in Turkey.
Kara E; Kelleci Çakır B; Sancar M; Demirkan K
Turk J Pharm Sci; 2021 Sep; 18(4):517-526. PubMed ID: 34496559
[TBL] [Abstract][Full Text] [Related]
13. Drug-Related Problems on a Palliative Care Unit.
Rémi C; Bauer D; Krumm L; Bausewein C
J Pain Palliat Care Pharmacother; 2021 Dec; 35(4):264-272. PubMed ID: 34460343
[TBL] [Abstract][Full Text] [Related]
14. Acceptability of pharmacist-led interventions to resolve drug-related problems in patients with chronic myeloid leukaemia.
Tan BK; Chua SS; Chen LC; Chang KM; Balashanker S; Bee PC
J Oncol Pharm Pract; 2021 Oct; 27(7):1644-1656. PubMed ID: 33040675
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of pharmacist interventions and commonly used medications in the geriatric ward of a teaching hospital in Turkey: a retrospective study.
Ertuna E; Arun MZ; Ay S; Koçak FÖK; Gökdemir B; İspirli G
Clin Interv Aging; 2019; 14():587-600. PubMed ID: 30962679
[TBL] [Abstract][Full Text] [Related]
16. Pharmacists' interventions on 2 years of drug monitoring in an oncology pediatric inpatient ward.
Agnol RD; Dos Santos MT; Michalowski MB; Einsfeld L
J Oncol Pharm Pract; 2022 Dec; 28(8):1754-1762. PubMed ID: 34605321
[TBL] [Abstract][Full Text] [Related]
17. Incorporating a clinical oncology pharmacist into an ambulatory care pharmacy in pediatric hematology-oncology and transplant clinic: Assessment and significance.
Ali K; Al-Quteimat O; Naseem R; Malhi SM; Wajdi M; Jahan N; Ansari SH; Shamsi TS
J Oncol Pharm Pract; 2021 Jun; 27(4):815-820. PubMed ID: 32633660
[TBL] [Abstract][Full Text] [Related]
18. Characterization of drug-related problems and associated factors in ambulatory patients in China.
Wang X; Yang J; Yu X; Wang Z; Wang H; Liu L
J Clin Pharm Ther; 2020 Oct; 45(5):1058-1065. PubMed ID: 32516504
[TBL] [Abstract][Full Text] [Related]
19. Drug-related problems with targeted/immunotherapies at an oncology outpatient clinic.
Kucuk E; Bayraktar-Ekincioglu A; Erman M; Kilickap S
J Oncol Pharm Pract; 2020 Apr; 26(3):595-602. PubMed ID: 31342849
[TBL] [Abstract][Full Text] [Related]
20. The role of the pharmacist in the multidisciplinary approach to the prevention and resolution of drug-related problems in cancer chemotherapy.
Boşnak AS; Birand N; Diker Ö; Abdi A; Başgut B
J Oncol Pharm Pract; 2019 Sep; 25(6):1312-1320. PubMed ID: 29984626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
